Post COVID Condition and Long‐Term COVID‐19 Impact on Hepatic Decompensation and Survival in Cirrhosis: A Propensity Matched Observational Study
ABSTRACT Aims Patients with cirrhosis are susceptible to decompensation events, including ascites, variceal bleeding (VB), hepatic encephalopathy, or death after COVID‐19 infection. Patients may experience post‐COVID condition (PCC) with multisystem involvement that persists for at least 2 months. M...
Saved in:
| Main Authors: | Prerna Sharma, Madhumita Premkumar, Rashmi Ranjan Guru, Anchal Sandhu, Kamal Kajal, Arka De, Sahaj Rathi, Nipun Verma, Sunil Taneja, Virendra Singh, Ajay Kumar Duseja |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-03-01
|
| Series: | JGH Open |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jgh3.70142 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19 in decompensated cirrhosis
by: O. V. Tashchyan, et al.
Published: (2021-01-01) -
Evaluating Disparities in COVID‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study
by: Umar Hayat, et al.
Published: (2024-12-01) -
Comparative effectiveness and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in patients with HBV-associated decompensated cirrhosis: insights from a retrospective analysis
by: Lu Chen, et al.
Published: (2025-08-01) -
Recompensation in patients with autoimmune hepatitis-related decompensated cirrhosis following immunosuppressive therapy
by: Yu Chen, et al.
Published: (2025-09-01) -
Radiomic Analysis of Contrast‐Enhanced CT Predicts Recompensation in Hepatitis B‐Related Decompensated Cirrhosis
by: Qiaofeng Chen, et al.
Published: (2025-03-01)